Single Center,Study on Evaluation of use of,â??AYURCOVâ?? as add on therapy for Treatment of SARS-CoV-2 Infection in COVID-19 Patients,at Tertiary Care Center.
Not Applicable
Completed
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: J22- Unspecified acute lower respiratory infection
- Registration Number
- CTRI/2020/06/026262
- Lead Sponsor
- Bhaktivedanta Hospital and Research Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 120
Inclusion Criteria
1.COVID -19 Positive patients
2.Agree to consent for the study.
3.All Age groups above 18 Years
4.All genders.
Exclusion Criteria
1. Unable to be followed-up during the trial
2. Current or future involvement in the active treatment phase of other interventional research studies (excluding observational/non-interventional studies) .
3. Any other clinical reason which may preclude entry in the opinion of the investigator.
4, Pregnant Women.
5.Patients who are on ventilator support .
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method